82
Participants
Start Date
February 28, 2020
Primary Completion Date
July 6, 2022
Study Completion Date
July 20, 2022
Vortioxetine
Vortioxetine 5, 10 and 20 mg/day, tablets, orally Patients will receive 5 mg vortioxetine once daily for one week. At visit 3, the dose will be increased to 10 mg/day for all patients. Thereafter the dose may be adjusted to 5, 10 or 20 mg/day.
Inje University Ilsan Paik Hospital, Goyang-si
Marienthali Kliinik, Tallinn
Seoul National University Bundang Hospital, Seongnam-si
Cabinet du Docteur Karim Boutayeb, Viersat
Azienda Ospedaliera Spedali Civili di Brescia-Universita degli Studi Di Brescia, Brescia
Centro de Saude de Lavadores, Vigo
University Clinical Hospital of Valladolid, Valladolid
Hospital Río Hortega, Valladolid
Chonnam National University Hospital, Gwangju
Fondazione Universitaria G.D'Annunzio Ce.S.I. Centro Ricerca (Centro Scienze del l'Invecchiamento..., Chieti
Centre de Recherche-Hopital Geriatrique de Charpennes, Villeurbanne
Azienda Ospedaliera di Perugia - Policlinico Monteluce, Perugia
Fondazione Santa Lucia IRCCS, Rome
Clinical Research Center Spolka z ograniczona odpowiedzialnoscia Medic-R Spolka Komandytowa, Poznan
MlynowaMed Specjalistyczny Psychiatryczny Gabinet Lekarski Joanna Lazarczyk, Bialystok
NZOZ Dom Sue Ryder - Pallmed Sp. z o.o., Bydgoszcz
CareClinic, Katowice
Centrum Zdrowia Psychicznego Biomed - Jan Latala, Kielce
Niepubliczny Zaklad Opieki Psychiatrycznej Mentis, Leszno
Centrum Medyczne Luxmed Sp.Z O.O., Lublin
Nzoz Syntonia, Pruszcz Gdański
Nowon Eulji Medical Center, Eulji University, Seoul
Samsung Medical Center, Seoul
Hospital Clinic i Provincial de Barcelona, Barcelona
Collaborators (1)
ICON plc
INDUSTRY
H. Lundbeck A/S
INDUSTRY